Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 7037
116th Congress(2019-2020)
To provide for quality assurance of COVID-19 reimbursements and reporting.
Introduced
Introduced
Introduced in House on May 27, 2020
Overview
Text
Sponsor
Republican
Introduced
May 27, 2020
Latest Action
May 27, 2020
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
7037
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Republican
Bill Posey
Florida
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

This bill (1) establishes documentation requirements for testing, treatment, and reporting related to COVID-19 (i.e., coronavirus disease 2019); and (2) makes it unlawful to knowingly report a false diagnosis of COVID-19. To receive a federal reimbursement for the cost of a COVID-19 diagnostic test or treatment, the request for reimbursement must document that the administered COVID-19 test has been approved, cleared, or authorized by the Food and Drug Administration.

Further, the Centers for Disease Control and Prevention must exclude from its official COVID-19 case and death counts any person who tested positive and requested federal reimbursement without the required documentation.

Additionally, any person who knowingly reports a false diagnosis of COVID-19 is subject to criminal fines and imprisonment for not more than 10 years.

Text (1)
Introduced in House
May 27, 2020
Actions (2)
05/27/2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
05/27/2020
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:42:48 PM
Copyright © 2024 Civic Bits LLC
Privacy Policy
Terms of Service
What's New
About